By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Plexxikon Inc. 

91 Bolivar Drive

Berkeley  California  94710  U.S.A.
Phone: 510-647-4000 Fax: 510-548-8014


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Plexxikon Inc. Announces Promising Preliminary PLX3397 Phase 1 Extension Data In Patients With Pigmented Villonodular Synovitis (PVNS) 5/15/2014 9:58:15 AM
Plexxikon Inc. Announces PLX3397 Data Presentations At American Society of Clinical Oncology 2014 Annual Meeting 5/15/2014 8:05:23 AM
Plexxikon Inc. Taps New CEO, COO 5/31/2013 8:43:22 AM
Plexxikon Inc. Announces Three-Year Survival in Zelboraf-Treated Metastatic Melanoma Patients 11/9/2012 9:57:57 AM
Plexxikon Inc. Announces European Approval of Zelboraf® for the Treatment of Patients With BRAF Mutation-Positive Metastatic Melanoma 2/21/2012 6:49:47 AM
Plexxikon Inc. Advances Novel Targeted Treatment PLX3397 in Blood Cancer 12/13/2011 6:53:20 AM
Plexxikon Inc. Advances Novel Targeted Treatment PLX3397 in Blood Cancer 12/12/2011 12:17:21 PM
Plexxikon Inc. Novel Agents Aim to Address Cancer Treatment in New Ways 11/14/2011 9:49:40 AM
Plexxikon Inc. Announces Combination Trials for Vemurafenib in Melanoma 6/2/2011 10:55:07 AM
Plexxikon Inc. Announces Data Presentations of Oncology Pipeline, Including Phase 3 Vemurafenib Data, at American Society of Clinical Oncology 2011 Annual Meeting 5/18/2011 9:52:57 AM
123456
//-->